A new GeneraLife study on male infertility in the Asia Journal of Andrology.
“A study has just been published in the Asian Journal of Andrology, which investigates the impact of the male factor of infertility on the results of medically assisted procreation.” From this new review by the GeneraLife group – comments Rossella Mazzilli, andrologist and endocrinologist at the GeneraLife center in Rome – emerges that:
A careful study of the male factor, even in the presence of a predominant female problem, is essential to quantify the couple’s reproductive potential.
The therapeutic potential must be carefully defined, to determine if there is scope for improving seminal parameters and / or for recovering spermatozoa surgically in the event of azoospermia.
It is always necessary to consider the time factor, the “treatment window” of the male partner, in relation to critical female characteristics such as maternal age and ovarian reserve.
“Therapeutic decisions regarding the treatment of couple infertility must be carefully weighed by balancing the impact of the male factor against the predominant characteristics of women, almost maternal age and ovarian reserve”.
In summary, it is always advisable to study the male partner, even if it is the woman who has the main problems of infertility, because in this way the results of the IVF cycles can be optimized.
GeneraLife